Over the last several years, while reviewing complex pediatric cases involving autism spectrum disorder, ADHD, developmental regression, sensory dysfunction, hyperactivity, and mixed neurodevelopmental presentations, I have repeatedly observed a similar biological pattern emerging across multiple layers of testing.
Importantly, this pattern often does not begin in the brain.
It begins in the gut, the mitochondria, the immune system, and the metabolites connecting them.
While no single mechanism explains every child, the consistency of these findings has led me to explore whether many seemingly unrelated biomarkers may actually represent different stages of the same biological cascade.
The pattern frequently includes:
• Evidence of mitochondrial stress and impaired energy production
• Dysbiosis with loss of key microbial functions
• Reduced colonocyte energy metabolism
• Intestinal barrier dysfunction
• Neuroactive microbial metabolites
• Excitatory neurotransmitter dominance
• Immune activation and inflammatory signaling
• Altered tryptophan metabolism
• Environmental toxicant and mycotoxin burden
• Genetic vulnerabilities affecting redox balance, neurotransmitters, methylation, and mitochondrial function
One of the most striking observations is that many children demonstrate signs of impaired butyrate utilization despite retaining butyrate-producing organisms within the microbiome.
In a healthy gut, colonocytes oxidize butyrate as their primary fuel source. This process maintains physiological hypoxia within the intestinal environment, helping support beneficial anaerobic bacteria and limiting expansion of oxygen-tolerant opportunistic species.
When mitochondrial function becomes compromised, butyrate oxidation may become impaired. The consequences can include altered oxygen gradients, disruption of microbial ecology, increased inflammatory signaling, barrier dysfunction, and changes in microbial metabolite production.
On testing, this frequently coincides with:
• Elevated calprotectin
• Elevated zonulin
• Dysregulated secretory IgA
• Increased dysbiosis indices
• Low or imbalanced short-chain fatty acid profiles
• Expansion of opportunistic organisms
• Reduced beneficial taxa including Lactobacillus and Methanobrevibacter species
At the same time, many children exhibit neuro-metabolic signatures suggesting altered neurotransmitter regulation.
Examples include:
• Elevated DHPPA and related Clostridial metabolites
• Elevated HVA
• Elevated DOPAC
• Increased HVA/VMA ratios
• Reduced microbial GABA production
• Elevated glutamate and aspartate
• Altered serotonin and kynurenine pathway metabolites
These findings suggest that microbial metabolism may influence dopamine, norepinephrine, GABA, glutamate, and serotonin signaling through multiple interconnected mechanisms.
Another recurring theme is mitochondrial dysfunction.
Common findings include:
• Elevated pyruvate
• Elevated citric, cis-aconitic, and isocitric acids
• Elevated succinate, fumarate, and malate
• Elevated 2-hydroxybutyrate
• Elevated orotic acid
• Significant ketosis despite adequate caloric intake
Collectively, these markers may indicate oxidative stress, impaired Krebs cycle efficiency, altered redox balance, and increased metabolic compensation.
Environmental contributors are also frequently present, including elevated toxic metals, PFAS metabolites, organophosphate metabolites, and mycotoxins capable of affecting mitochondrial function, barrier integrity, immune regulation, and neuroinflammatory pathways.
What is particularly compelling is not any single biomarker.
It is the repeated appearance of the entire pattern.
When viewed sequentially, the cascade often resembles:
Early-life insult → microbiome disruption → mitochondrial dysfunction → impaired butyrate utilization → barrier dysfunction → altered microbial ecology → neuroactive metabolite production → neurotransmitter dysregulation → immune activation → neuroinflammatory signaling.
This does not mean that autism or ADHD are simply “gut disorders.”
Neurodevelopmental conditions are complex, multifactorial, and influenced by genetics, environment, immune function, metabolism, and brain development itself.
However, the data increasingly suggest that the gut-brain axis may be a significant contributor in at least a subset of children.
The encouraging part is that many of these pathways are measurable and potentially modifiable.
The goal is not to chase symptoms.
The goal is to understand the biology driving them.
— Mohammed Attallah
Biomelogic